Provided by Tiger Trade Technology Pte. Ltd.

Valneva SE

5.06
+0.09501.92%
Volume:4K
Turnover:20.59K
Market Cap:479.65M
PE:-2.77
High:5.15
Open:5.00
Low:4.99
Close:4.96
52wk High:12.25
52wk Low:4.75
Shares:94.89M
Float Shares:85.93M
Volume Ratio:0.60
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8266
EPS(LYR):-1.6084
ROE:-109.57%
ROA:-14.54%
PB:5.49
PE(LYR):-3.14

Loading ...

Valneva Sets Date for H1 2026 Results as Vaccine Pipeline Advances

TIPRANKS
·
Jul 23

Press Release: Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026

Dow Jones
·
Jul 22

Analysts Are Bullish on These Healthcare Stocks: Valneva (VALN), Regeneron (REGN)

TIPRANKS
·
Jul 22

Valneva Shareholders Back All AGM Resolutions as Board Elects New Chair

TIPRANKS
·
Jun 26

Press Release: Valneva Announces Successful Outcome of Its Annual General Meeting

Dow Jones
·
Jun 25

Valneva files to sell 31.79M ordinary shares for holders

TIPRANKS
·
Jun 05

Valneva Ramps Up June 2026 Investor and Medical Conference Presence

TIPRANKS
·
Jun 01

First Berlin reiterates Buy on Valneva, cuts price target to EUR 4.5

Reuters
·
May 28

Valneva (VALN) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 27

Valneva SE reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Valneva Q1 EPS $(0.42) Misses $(0.21) Estimate, Sales $36.189M Miss $46.270M Estimate

Benzinga
·
May 13

Press Release: Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Dow Jones
·
May 13

Valneva SE expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
May 11

Valneva Sets May 13 Date to Present First-Quarter 2026 Results

TIPRANKS
·
May 06

Valneva Raises Up to €84 Million via Private Placement Tied to Lyme Vaccine Milestone

TIPRANKS
·
May 01

Goldman Sachs Downgrades Valneva to Sell From Neutral, Adjusts Price Target to $4.90 From $7.50

MT Newswires Live
·
Apr 22

Federal Court Reportedly Halts Kennedy's Vaccine Panel, Putting COVID, Flu And RSV Shots At Risk

Benzinga_recent_news
·
Apr 21

Valneva Showcases Chikungunya Vaccine Progress at World Vaccine Congress in Washington

TIPRANKS
·
Mar 27

Jefferies says Valneva stock weakness presents buying opportunity

TIPRANKS
·
Mar 24

Valneva Down Over 36%, on Pace for Largest Percent Decrease Since September 2021 -- Data Talk

Dow Jones
·
Mar 23